PMID- 26995199 OWN - NLM STAT- MEDLINE DCOM- 20160617 LR - 20221207 IS - 1214-6994 (Print) IS - 1214-6994 (Linking) VI - 117 IP - 1 DP - 2016 TI - High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus. PG - 5-17 LID - 10.14712/23362936.2016.1 [doi] AB - The link between vitamin D and type 2 diabetes mellitus (T2DM) is intensively studied. This study aims to define the serum concentration of 25-hydroxyvitamin D (25-OH D) and to investigate the relationship between 25-OH D status, glycated hemoglobin (HbA1c) and body composition in postmenopausal women with T2DM and in non-diabetic controls. In this cross-sectional study, 75 women with T2DM and 32 control subjects were selected. Serum 25-OH D, intact parathyroid hormone (PTH), calcium, fasting glucose and HbA1c, were measured. The mean 25-OH D level was 21.4+/-11.4 ng/ml (range 4.1-50.7 ng/ml) in diabetic women and 30.3+/-9.4 ng/ml (range 10.8-54.2 ng/ml) in control group (p<0.001). The prevalence of hypovitaminosis D (<30 ng/ml) was higher in vitamin D3 non-supplemented T2DM women (89% vs. 63% controls); the difference diminished in vitamin D3 (500-1000 IU per day) supplemented subgroups (45% diabetics vs. 42% controls). In T2DM women, 25-OH D levels were not associated to HbA1c, duration of diabetes, fasting glucose and PTH levels, however, 25-OH D levels negatively associated with body mass index (p=0.011), total body fat mass (p=0.005) and total body lean mass (p=0.004). The prevalence of hypovitaminosis D is higher in non-supplemented postmenopausal women with T2DM than in non-diabetic controls (89% vs. 63%). Obesity is a risk factor for vitamin D insufficiency in T2DM postmenopausal women. Further studies evaluating relationships between fat, muscle, bone and vitamin D metabolism in T2DM patients are warranted. FAU - Raska, Ivan Jr AU - Raska I Jr AD - 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. Ivan.Raska@vfn.cz. FAU - Raskova, Maria AU - Raskova M AD - 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. FAU - Zikan, Vit AU - Zikan V AD - 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. FAU - Skrha, Jan AU - Skrha J AD - 3rd Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Czech Republic TA - Prague Med Rep JT - Prague medical report JID - 101227436 RN - 0 (Glycated Hemoglobin A) RN - 1406-16-2 (Vitamin D) RN - A288AR3C9H (25-hydroxyvitamin D) SB - IM MH - Absorptiometry, Photon/methods MH - Aged MH - Body Composition MH - Body Mass Index MH - Cross-Sectional Studies MH - Czech Republic/epidemiology MH - *Diabetes Mellitus, Type 2/blood/epidemiology MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Middle Aged MH - *Obesity/diagnosis/epidemiology MH - Postmenopause/*metabolism MH - Prevalence MH - Risk Factors MH - Vitamin D/analogs & derivatives/blood MH - *Vitamin D Deficiency/blood/diagnosis/epidemiology OTO - NOTNLM OT - Body composition OT - Hypovitaminosis D OT - Parathyroid hormone OT - Type 2 diabetes mellitus OT - Vitamin D EDAT- 2016/03/21 06:00 MHDA- 2016/06/18 06:00 CRDT- 2016/03/21 06:00 PHST- 2016/03/21 06:00 [entrez] PHST- 2016/03/21 06:00 [pubmed] PHST- 2016/06/18 06:00 [medline] AID - pmr_2016117010005 [pii] AID - 10.14712/23362936.2016.1 [doi] PST - ppublish SO - Prague Med Rep. 2016;117(1):5-17. doi: 10.14712/23362936.2016.1.